453 related articles for article (PubMed ID: 27325106)
1. Curcumin in Treating Breast Cancer: A Review.
Wang Y; Yu J; Cui R; Lin J; Ding X
J Lab Autom; 2016 Dec; 21(6):723-731. PubMed ID: 27325106
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets of curcumin in breast cancer (Review).
Song X; Zhang M; Dai E; Luo Y
Mol Med Rep; 2019 Jan; 19(1):23-29. PubMed ID: 30483727
[TBL] [Abstract][Full Text] [Related]
3. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of curcumin action: signal transduction.
Shehzad A; Lee YS
Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer.
Sinha D; Biswas J; Sung B; Aggarwal BB; Bishayee A
Curr Drug Targets; 2012 Dec; 13(14):1799-819. PubMed ID: 23140290
[TBL] [Abstract][Full Text] [Related]
6. Curcumin for chemoprevention of colon cancer.
Johnson JJ; Mukhtar H
Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
[TBL] [Abstract][Full Text] [Related]
7. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism].
Di GH; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1764-8. PubMed ID: 14642080
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
10. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
11. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin.
Einbond LS; Wu HA; Kashiwazaki R; He K; Roller M; Su T; Wang X; Goldsberry S
Fitoterapia; 2012 Oct; 83(7):1160-8. PubMed ID: 22828666
[TBL] [Abstract][Full Text] [Related]
12. Multi-targeted therapy by curcumin: how spicy is it?
Goel A; Jhurani S; Aggarwal BB
Mol Nutr Food Res; 2008 Sep; 52(9):1010-30. PubMed ID: 18384098
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets of curcumin for cancer therapy: an updated review.
Kasi PD; Tamilselvam R; Skalicka-Woźniak K; Nabavi SF; Daglia M; Bishayee A; Pazoki-Toroudi H; Nabavi SM
Tumour Biol; 2016 Oct; 37(10):13017-13028. PubMed ID: 27468716
[TBL] [Abstract][Full Text] [Related]
14. Curcumin: the spicy modulator of breast carcinogenesis.
Banik U; Parasuraman S; Adhikary AK; Othman NH
J Exp Clin Cancer Res; 2017 Jul; 36(1):98. PubMed ID: 28724427
[TBL] [Abstract][Full Text] [Related]
15. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
16. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.
Catania A; Barrajón-Catalán E; Nicolosi S; Cicirata F; Micol V
Breast Cancer Res Treat; 2013 Aug; 141(1):55-65. PubMed ID: 23959397
[TBL] [Abstract][Full Text] [Related]
17. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.
Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K
Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280
[TBL] [Abstract][Full Text] [Related]
18. The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
Guerram M; Jiang ZZ; Yousef BA; Hamdi AM; Hassan HM; Yuan ZQ; Luo HW; Zhu X; Zhang LY
Oncotarget; 2015 Sep; 6(26):21865-77. PubMed ID: 26068969
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
Lin HP; Kuo LK; Chuu CP
Phytother Res; 2012 Jan; 26(1):122-6. PubMed ID: 21567511
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Kunnumakkara AB; Anand P; Aggarwal BB
Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
